Drug recall
ML09143 R170.86 w/SBM Medicated
FDA recall event 93325 · Class II · Cargill, Inc Corporate Headquarters
Key facts
| Event ID | 93325 |
|---|---|
| Recall numbers | V-0017-2024 |
| Recalling firm | Cargill, Inc Corporate Headquarters |
| Product type | Veterinary |
| Products | ML09143 R170.86 w/SBM Medicated |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Elevated monensin |
| Initiation date | Oct 30, 2023 |
| Report date | Nov 15, 2023 |
| Termination date | Jan 22, 2024 |
| City | Wayzata |
| State | MN |
| Country | United States |
| FEI number | 2129346 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: